Major Depression

MagVenture Inc., a provider of transcranial magnetic stimulation, has received clearance from the US Food and Drug Administration for a new protocol that cuts the time of each treatment session down to 3 minutes, the company announced.

Articles

The effectiveness of the vast majority of self-care interventions suggested for children and young people with anxiety and depression has not been evaluated, new research shows.

Greater depressive and anxiety symptoms at baseline predicted a better response to treatment with synchronized transcranial magnetic stimulation (sTMS) for major depressive disorder (MDD), according to a study.

Older adults who are prescribed medication for depression by primary care physicians often fail to initiate them or to continue using them as directed, a Dutch study suggests.

Adjunctive testosterone treatment in men is associated with a significant drop in depressive symptoms, compared with placebo, according to a systematic review and meta-analysis published online in JAMA Psychiatry.

More frequent in-person social interaction is linked with a significantly lower risk of symptoms of major depression and posttraumatic stress disorder (PTSD) in US military veterans, according to a study published online.

Pages

Blogs

BLOG: This year’s Psych Congress returned, time and again, to the theme of us needing to reconnect with a larger experience of the world in order to find a path out of depression.

BLOG: The logical endpoint of population-based screening for perinatal depression is remission of depression in those who screen positive. Otherwise screening is just an empty endeavor.

BLOG: Michael Pollan, author of The Omnivore’s Dilemma and The Botany of Desire, has turned his spotlight of curiosity onto the subject of psychedelics with his new book How to Change Your Mind.

Pages

Slideshows

Get expert insight on attention-deficit/hyperactivity disorder, major depressive disorder, and addiction, gleaned from presentations at the 2018 Elevate by Psych Congress conference.

Posters

Justin Barnes, PhD; Brandon Coleman, BS; Sylvie Stacy, MD; Tsao-Wei Liang, MD; Stanley Caroff, MD; Greg Salinas, PhD
David G Brock, MD; W. Scott West, MD; Todd Hutton, MD; Kenneth P. Pages, MD; Timothy J. Kane, MD
Kasim Pendi, NA; Arif Pendi, MS; Jahanzeb Ashraf, MS; Kate Wolitzky-Taylor, PhD; Danny Lee, BS, BA; Jeffrey Sugar, MD; Joshua Lee, BS; David Baron, DO, Msed
Suresh Durgam, MD; Changzheng Chen, PhD; Raffaele Migliore, MA; Chandran Prakash, MD, MPH; Michael Thase, MD; Rocsanna Namdar, PharmD

Video

Drs. Raison and Patrick

Psych Congress cochair Charles Raison, MD, recently discussed his research and perspectives in an extensive interview with Rhonda Perciavalle Patrick, PhD, who runs the FoundMyFitness website.

PHQ-9

Saundra Jain, MA, PsyD, LPC, a Psych Congress Steering Commitee member, explains the Patient Health Questionnaire (PHQ-9), the gold standard measurement tool in major depression.

Mary Kay Lobo

Mary Kay Lobo, PhD, an assistant professor at the University of Maryland School of Medicine, Baltimore, explains research which suggests a specific gene, Slc6a15, may be central to depression.

Audio

Two members of the Psych Congress Steering Committee have been featured on an ABC News podcast which grew out of a newsman's newfound interest in meditation.